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ABSTRACT 
 
The numerous perceived health benefits and the growing awareness about probiotics have caught the 
attention of the food industry. Food companies are increasingly manufacturing foods with incorporated 
probiotic bacteria, which fall under the new category of foods called Functional Foods. Probiotic dairy 
products such as yogurts containing L. acidophilus and Bifidobacterium spp. constitute a significant 
amount among the commercially available probiotic foods. Functional foods have been developed in most 
food categories and even by conservative estimates, the global market size already exceeds that for 
organic foods. In addition to providing consumers options for improving their health and well-being, 
functional foods such as probiotics in dairy products are an attractive market sector, providing new 
economic opportunities. 
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INTRODUCTION  
Probiotic food products have been consumed by human 
beings in the form of fermented foods, for many years 
[1,2,3]. According to the report by FAO/WHO, 
probiotics are: “Live microorganisms which, when 
administered in adequate amounts, confer a health 
benefit to the host”. The most common types of 
probiotics are Lactic acid bacteria and include specie 
from the Lactobacillus, Pediococcus and 
Bifidobacterium genera. Various species including 
Lactobacillus rhamnosus and Bifidobacterium have 
mainly been used as probiotics over the years [4,5]. An 
important characteristic of probiotic bacteria is that they 
need to survive through the gastro intestinal track of the 
host. As S. thermophilus and L. bulgaricus are not 
expected to survive and grow in the host’s intestinal 
tract, they are not categoried as probiotics by most 
scientists  
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Probiotic bacteria are grow in the host’s intestinal tract, 
they are not categorized as probiotics by most scientists 
and are therefore considered as yogurt cultures [6]. 
Hence a probiotic yogurt will typically contain 
conventional yogurt starters and additional probiotic 
bacteria so as to provide health benefits in humans by 
creating an improved balance in the flora of the 
intestines [7]. Besides of these advantages of probiotics, 
and probiotic food there is  very less information is 
available on the synergistic effects of prebiotics and 
hydrolyzed milk on the growth and survival of 
bifidobacteria spp., which could lead to new products for 
the dairy market. 
Fermented milk and probiotic bacteria 
Fermented milk has been used throughout the history of 
mankind. Nearly every civilization have developed some 
type of fermented milk product such as buttermilk, 
labneh, acidophilus milk and yogurt, which were familiar 
to many people, although the fermentation process was 
not defined yet. Yogurt, which came from the Turkish 
term in the eighth century as- yoghurut [8] and the 
spelling changed over time to the present spelling in the 
eleventh century. Yogurt is defined as- product obtained 
 by the fermentation of milk with cultures of 
streptococcus thermophilus and lactobacillus delbrueckii 
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ssp. bulgaricus, however, ―yogurt-like products are 
made by substituting L. bulgaricus by other 
Lactobacillus species for the fermentation of milk or 
yogurt containing probiotic bacteria [9]. 
The fermentation process of dairy products and its 
bacteria have received great attention over the decades 
after discovering the importance of viable bacteria in 
food for health benefits. At the beginning of the last 
century first scientific work had been done by 
Metchnikoff to investigate the beneficial effects of 
fermented milk for human health. Numerous scientific 
studies have been published describing the health benefit 
associated with the consumption of fermented dairy 
products [10].The lactic acid bacteria (yogurt bacteria; 
Lactobacillus delbrueckii ssp. bulgaricus and 
Streptococcus thermophilus) do not inhabit the human 
and animal intestinal tract, nor do survive passing 
through the digestive system [11]. Therefore, to get the 
beneficial health effects associated in the fermented 
dairy products, there has been and increase interest in the 
incorporation of the intestinal species Lactobacillus 
acidophilus and Bifidobacterium species in the 
fermented milk products [12,13,14], these include 
fermented liquid milks, ice cream, yogurt, and cheese 
and in soya milk and soya yogurt [15,16,17]. A probiotic 
is defined classically as a viable microbial dietary 
supplement that beneficially affects the host through its 
effects in the intestinal tract. This definition, however, 
was initially intended for use with animal feed products. 
For human nutrition, the following definition has been 
proposed: Probiotics are viable microorganisms that are 
beneficial to the host when administered in appropriate 
quantities [18].  
In the last decade, the use of probiotics in Fermented 
dairy product and feed product applications has a 
noticeable interest and develop.  
These organisms play significant role in lowering the pH 
of the large intestine through the release of lactic and 
acetic acid [19] 
.A large number of probiotic strains Isolates from food, 
especially dairy products, but also from many 
applications samples for human, and nutrients for 
animals. All commercially available isolates of the 
genera Lactobacillus and Bifidobacterium were 
identified and compared with reference strains from 
official culture collections (ATCC, DSMZ, LMG, 
CCUG, and others).  
As bifidobacteria are used as probiotic cultures in 
commercial dairy products, the questions arose , which 
species are used? [20,21].  In general, there are 56 
species of lactobacillus and 29 species of Bifidobacteria, 
which used worldwide in dairy products [14].  
However, the main species of lactobacillus and 
Bifidobacteria had been reported in literature such as; L. 
lactis, L. casei, L. paracasei and more. B. longum, B. 
infantis, B. breve, B. lactis and B. bifidum [14]. Recent 
experience revealed that B. animalis had been applied 
frequently in fermented dairy products due to the fact 
that this species is somewhat less sensitive against 
acidification (pH below 4.2) and elevated oxygen 
tolerance, which is remarkable within the Bifidobacteria 
[22, 23]. 
Bifidobacteria are unique in many other respects.  
Human related sequence of bifidobacteria differs from 
both homo and hetero-fermentative bacteria in that they 
metabolize carbohydrates by aspecial enzyme called 
Fructose-6-Phosphate Phosphoketolase (F6PPK), which 
also metabolize Fructooligosaccharides (FOS) which are 
polymers of fructose and cannot be metabolized by either 
human digestive enzymes or most undesirable gut 
microorganisms.  
The use of Bifidobacteria in fermented milk shows that it 
has very slow properties and it requires specific growth 
factor, known as bifidogenic factors, these are 
carbohydrates such as N-acetyl-D- glucosamine and 
lactulose found in human milk [24] and processed milk 
products, respectively. ― Unlike yogurt bacteria, 
probiotic bacteria grow very slow. Moreover, it has 
shown that breast-fed infants have higher numbers of 
Bifidobacterium than bottle-fed ones [25]. 
The use of bifidobacteria in fermented milk has many 
benefits to human and animals by several mechanisms 
[26, 25,27,28].  
Therefore, it has been very important to determine the 
efficacy of the product containing probiotics, such as the 
acceptance of the product by the consumers and the 
survival of probiotic microorganisms during its 
production. In general, the food industry has applied the 
recommended level of 106 CFU/g at the time of 
consumption for Lactobacillus acidophilus, 
bifidobacteria and other probiotic bacteria [14,29]. 
Although milk contain the essential nutrients for the 
growth of bifidobacteria, but the level of amino acids and 
peptides insufficient to provide the ideal condition for 
rapid their growth and survival [30,31].  
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In consequences bifidobacteria have been used only to 
limited extent in commercial fermented milk [31,1] in 
spite that fermented milk is the preferred carrier for 
bifidobacteria. 
The growing understanding of the relationship between 
diet and health increased the demand for food with   
specific benefit beyond their basic nutrition such as 
improving the health and well being of human. 
This food is called functional food However, Functional 
food has defined as one, which provides a specific health 
benefit over and above its normal nutritional status [32]. 
Moreover, the functional foods must remain as foods 
(not capsules, etc.) and they must also reveal their effects 
in amount that can usually be expected to be consumed 
in the diet.   
It has been suggested that food will use as functional 
when it has shown beneficial effect on one or more target 
in the body and that beside their nutritional effects such 
as well-being and health of the host [33].  
The old generation of functional foods indicates of using 
supplements to the food to increase their nutrition and 
health effects such as vitamins and micronutrient. 
However, in the new concept of functional foods there 
was more interest in the gastrointestinal interactions [34], 
that led for more interest in the dominated organisms in 
the gastrointestinal tract (indigenous microflora) which 
found to beneficially effect human health, which known 
as probiotic bacteria.  Therefore, the use of probiotic 
micro-flora was one of the most promising areas for the 
development of functional foods in the recent studies 
[35] because of what probiotics has established a great 
benefit to human health. 
Bifidobacteria were the most dominated organisms in the 
gastrointestinal tract and their viability and metabolic 
activity have shown very beneficial effects on the health 
of the gastrointestinal tract [36] and that always related 
to the presence of a suitable environment and nutrients, 
which are very important for the viability and activity, 
for bifidobacteria to use it in the bowel as carbon and 
energy source, these compound were referred to as 
―bifidogenic factors[37].  
At present, probiotics products and especially probiotics 
dairy foods are marketed successfully all over the world 
because of their acceptance of consumer and the 
awareness about their positive aspect for the health 
benefits. 
Health benefits for human 
HEALTH BENEFITS 
Bacteria have a reputation for causing disease, but a 
growing body of scientific evidence suggests that you 
can treat and even prevent some illnesses with foods and 
supplements containing certain kinds of live bacteria. For 
example, Metchnikoff related the longevity of 
Bulgarians to the present of Lactobacillus bulgaricus in 
the souring milk -yogurt. Moreover, in the Northern 
Europeans consume a lot of these beneficial 
microorganisms in the dairy products, because of their 
tradition of eating foods fermented with bacteria, such as 
yogurt and cheese, these beneficial bacteria have named 
later as probiotics. 
Probiotic microflora displays numerous health benefits 
beyond providing basic nutritional value. The health 
benefit reported of probiotics is the improvement in gut 
health and the prevention of intestinal infections and 
stimulating the immune system [38]. Infection 
prevention is increasingly preferred over using the 
traditional action by chemotherapy with antibiotics, that 
rise the concern over development of antibiotic 
resistance has placed probiotics at the fore.  
The principal mechanism for this action is known as 
competitive colonization or competitive inhibition 
[39,40,41,42]. This is described as the creation of 
probiotic bacteria in the human intestine, which acts as a 
vital barrier to invasion by pathogens in the 
gastrointestinal tract of the human host. Over 90% of the 
total cells in the body are present as bacteria in the colon, 
getting 1012 CFU (Colony Format Unite) for every gram 
of large intestinal contents [43,44]. Under natural 
conditions, a protective gut microflora develops and 
there is no need for a bacterial supplement [45] but the 
changing food habits and lifestyle force us to take 
processed food, which affects our access to, and 
colonization, by probiotics. Moreover, we also consume 
antibacterial substances ranging from vinegar to 
antibiotics. To reside in the gut, when ingested, probiotic 
bacteria are resistant to gastric acidity and bile salts [46] 
and therefore pass through the upper gastrointestinal 
tract and have the ability to adhere to the intestinal 
mucosa. Further, the  probiotics‘ secretion of by products 
such as lactic acid and acetic acid lower the pH in the 
intestine and producing hydrogen peroxide inhibiting the 
growth of pathogens and helped to speed pathogens 
through the intestines [47,48]. 
 The enhancement of the immune system is another 
reported health benefit of probiotics [49,50], as it appears 
that this effect by balancing control of pro-inflammatory 
and anti-inflammatory cytokines [51,14] and therefore
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probiotics are considered as immune-stimulatory agent 
and an important tools to prevent intestinal 
inflammation, stop gut mucosal dysfunction and 
decrease hypersensitivity [52].  
Recently, there is a relatively large volume of scientific 
literature basis supporting the use of probiotics for 
diarrhoea has started to become established. Probiotics 
have been shown effectiveness in the prevention of 
several types of diarrhea, including antibiotic-associated 
diarrhea, bacterial and viral diarrhea (including travelers‘ 
diarrhea), as well as that caused by lactose intolerance 
[53]. It is thought that this action is due to the secretion 
of antimicrobial polypeptides known as bacteriocins and 
that by; reduction in gastrointestinal pH through 
stimulation of lactic acid-producing bacteria; a direct 
antagonistic action on gastrointestinal pathogens; 
competition with pathogens for binding and receptor 
sites; improved immune function; and competition for 
limited nutrients [54). It seems that the effect of 
probiotics on travellers diarrhea depends on the bacterial 
strain used and the destination of the travelers [55].  
Observational data suggest that consumption of 
fermented dairy products is associated with a lower 
prevalence of colon cancer, which is suggested that 
probiotics are capable of decreasing the risk of cancer 
[56]. 
The Mechanisms described by Inhibition of carcinogens 
and pro-carcinogens, Inhibition of bacteria capable of 
converting pro-carcinogens to carcinogens [57]. 
Moreover, probiotic and especially bifidobacteria has 
shown to increase the α- and β-galactosidase activities in 
the faecal samples after feeding with the fermented milk 
containing probiotics, which is considered to be an 
important probiotic quality, as it supports lactose 
digestion in the intestine and compensates for lactase-
deficiency [14,58,59].  
Playne[60] suggested that Health benefits imparted by 
probiotic bacteria are strain-specific and not species- or 
genus- specific. For example the strains Lactobacillus 
rhamnosus GG (Valio), Lactobacillus paracasei Shirota 
(Yakult), and Bifidobacterium Lactis Bb12 (Chr. 
Hansen), L. acidophilus La5 (Chr. Hansen) have the 
strongest human health efficacy data, against some or all 
of: lactose intolerance; rotaviral diarrhea; antibiotic-
associated diarrhea and some other bacterial diarrheas 
and infections. B. animalis found to stimulate the 
immune response in vivo [61,62]. Moreover, it has 
improved in control study the useful of Bifidobacterium 
lactis strain Bb12 in prevention of acute diarrhea in 
infants [63,64,65] and same by Lactobacillus GG [66]. 
Bifidobacterium lactis Bb12 well known in their ability 
to improve the growth of children when supplement in 
their formula. Candida can also be suppressed or 
controlled by viable L. acidophilus. It is also thought 
thatnon-viable forms exert such control but to a lesser 
extent [67]. 
The only prebiotics for which sufficient data have been 
generated to allow an evaluation of their possible 
classification as functional food ingredients are the 
inulin-type fructans, which include native inulin, 
enzymatically hydrolyzed inulin or oligofructose, and 
synthetic fructooligosaccharides [68,69,72].  
Inulin 
Inulin is natural food ingredient, which found in many 
vegetables and obtained industrially from chicory roots 
[70]. Usually GFn is the symbolized use for inulin as 
polysaccharides mixture, where G is the glucose moiety, 
F is the fructose moiety and (n) equals the number of 
fructose moieties linked by β (2→1) linkages (Figure 
2.1). This bonding renders it resistant to hydrolysis, both 
in the stomach and the intestine [71]. The degree of 
polymerization (DP) of inulin typically ranges from 2 to 
60. Usually 10% of the inulin extracted from chicory 
roots is sucrose and fructose, and 30% is oligosaccharide 
(DP=10). The production process of inulin naturally 
from chicory roots is by diffusion in hot water, followed 
by refining and spry drying.  
The nutritional properties of inulin as a supplement to 
the healthy foods is obtained when inulin is not broken 
down in the upper digestive systems of human and 
should be given energy value of 6.28 kj/g [71], 
fermented by the intestinal flora causing increase in the 
biomass, producing of short chain fatty acids and 
decrease in the pH, and significant increase of 
bifidobacteria in the colon and inhibits the growth of less 
beneficial bacteria, [72]. So using these ingredients in 
food allows improving the nutrition value of the 
products, by reducing the calorie content and increasing 
the bifidus-promoting capacities. 
Inulin has natural taste, colourless and minimal influence 
on the natural characteristics of the products. Inulin is 
highly soluble fiber ingredient, which gives its more 
importance in the dairy industries such as milk drink, 
yogurt, and cheeses. Combining inulin with sweetness 
improves the taste of products giving more sugar-like 
sweetness. Atconcentration of 40-45% inulin form a fatty 
tasting solution, which make it highly used in the free-fat 
products to give the smooth creamy texture and taste; 
Inulin has successfully applied in fat-reduced table 
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spread, cheese products, meat products, frozen desserts, 
fillings, sauces and meat replacers. [73,74].  
Using the food as vehicles for inulin considering in its 
ability to keep the inulin save to the intestine where the 
bifidobacteria inhabit, but yogurt has shown to be the 
best choice for that purpose. However, bio-yogurt - with 
inulin showed problem in transferring the short chain 
length of the inulin because of the possibility to interfere 
too much with the inter-micellar bonding of the casein, 
that why it is important to watch the optimum level of 
casein to give maximum gel to natural yogurt with 
inulin. Moreover, the different effect of the yogurt 
culture or Bifidobacterium spp. on the different levels of 
oligosaccharides which generate undesirable acids when 
utilize some of the inulin and the effect of the inulin on 
the gel strength, viscosity and flavour of the natural 
yogurt.  
Oligosaccharides 
Oligosaccharides of various types found in common 
foods such as fruit, vegetables, milk and honey [75]. 
Oligosaccharides often have between 2-10 polymers of 
sugar. It is often contain low levels of monosaccharide 
and di- or polysaccharides. They have various properties 
depended on their molecular- weight; low molecular- 
weight can used in food freezing temperature and the 
high once use for thickness and increase body and mouth 
feel.  
Grittenden and Playne [76] have selected food grade 
oligosaccharides and listed them: Fructo-
oligosaccharides (FOS), Galacto-oligosaccharides 
(GOS), Lactulose, Lactosucrose, Malto-oligosaccharides, 
Isomalto-oligosaccharides, soybean- oligosaccharides 
and xylo-oligosaccharides in the commercial 
productions. Of these food grade oligosaccharides there 
are some of them, which have the bifidogenic effect and 
health promoting properties; such as Fructo-
oligosaccharides and Galacto-oligosaccharides. 
Galactooligosaccharides 
Galacto-oligosaccharides (GOS) are found in the human 
milk and proved to have the bifidogenic promoting effect 
for the breast-fed infants [77,78,79].  GOS is primary 
production from Cow‘s Whey-derived lactose [80]. The 
lactose solution is converted to GOS by the action of β-
galctosidase, which has transgalactosylation activity 
(Figure 1). GOS have a DP of 2 to 10 units, which are 
able to pass through the upper gut without hydrolysed by 
digestive enzymes, to reach the large intestine and 
beneficially affects the host by stimulating the growth 
and/or activity of target flora only. 
 
Figure 1: Production of galactooligosaccharide from cows‘ milk  
GOS found in the breast milk at level of 1g/L [81]. 
Therefore, it is considered as bifidogenic factors in 
fermented milk products and baby foods. GOS consist of 
number of β1-6 linked galactosyl residues bound to a 
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terminal glucose unit via α1-4 linkage [82], that make 
GOS utilized by some probiotics (stimulating their 
growth) depend on their enzymes and especially 
Lactobacillus group [83]. GOS can be used in food 
contributing to both thickness and mouth-feel, 
sweeteners as it sweetness is 35% of sucrose and source 
for fiber. They have calorie value of 1.7Kcal/g [84]. 
FructooligosaccharidesFructo-oligosaccharides (FOS) 
and Inulin are the most classified as bifidogenic 
oligosaccharides in productions.  Fructooligosacchrides 
(FOS) contains between 2- 4 of β (2→1) linked fructose 
units linked to the terminal α-D-glucose residue. The 
natural way of FOS productions is by enzyme hydrolysis 
of Inulin (Figure 2). Therefore, there is no difference 
from the chemical view between inulin and FOS, but the 
DP for FOS is between 2-10 units with an average of 4 
[85]. 
 
 
 
Figure 2: Inulin and oligofructose manufacturing process 
Oligofructose is more soluble than sucrose and Inulin, 
provides 30-50% of the sweetness of table sugar. It is 
considered to be low-calorie ingredients which around 
1.5 Kcal/g.  Inulin and FOS are widely found in nature 
and manufactured by companies such as Orafti, Sensus 
and Cosucra.  A lot of scientific studies in-vivo have 
shown that FOS (RAFTILOSE® P95) and Inulin 
(RAFTILINE® ST) from ORAFTI have bifidogenic 
effect on host; When consumed at a dose of 5g/day for 
oligofructose and ≤ 8 g/day for inulin, they significantly 
modify the composition of the intestinal (faecal) flora, 
selectively increasing the numbers of Bifidobacteria and 
reducing the harmful bacteria [86,87,88,89,90, 
91](Figure 3). 
 
 
Figure 3: Increase in Bifidobacteria after intake of 15g/day of inulin (92. Adapted from Gibson et al., 1995) 
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Food for Specified Health Use (FOSHU) is unique 
system in Japan for approving ingredients/foods with a 
functional claim [93,94]. Prebiotic containing foods are 
most common in this category because the most FOSHU 
food designed for the gastrointestinal health benefits.  
The survival of probiotics including L. acidophilus, L. 
Casei and Bifidobacterium spp. was improved by adding 
of FOS (P95, from ORAFTI) at 1.5% w/v to yogurt 
containing these microorganisms [95].  
Inulin and oligofructose have found to improve the 
bioavailability of minerals such as calcium, magnesium 
and iron and they increase the absorption of calcium and 
magnesium in the large intestine [96,97]. Use 
oligofructose in the diet by 15g/day produce substantial 
changes in the intestinal microflora and increase the 
faecal bifidobacteria count and reduce the potential 
pathogens such as Clostridium, E. coli. It has found that 
symbiotic supplements of Oligofructose and 
L.rhamnosus and B. animalis subsp. Lactis improved the 
immune responses and stopped colon tumors.  Prebiotics 
have shown resistance to gastrointestinal infection 
because of their stimulatory effect on Bifidobacterium 
spp., which produces several anti- pathogenic 
mechanisms [98]. 
Although prebiotics can help to increase the beneficial 
bacteria in the gastrointestinal tract, a general increase in 
the beneficial bacterial population may however not 
necessarily contribute to increased health effects, as it is 
strain related. 
 
Biochemistry study of the fermentation process of 
bifidobacteria in milk 
The common result of the bacterial fermentation process 
is lactate. It is referred to the bacteria, which produce 
lactate in their fermentation as Lactic Acid Bacteria 
(LAB). Some of these organisms require very complex 
nutrition, which is related to their environments such as 
plant, milk and intestinal of animals or humans. Lactic 
Acid Bacteria are strictly fermentative and some are 
oxygen tolerant, such as Streptococcus. Others are 
obligate anaerobes such as Bifidobacteria spp. but some 
can tolerant oxygen in the presence of carbon dioxide 
(CO2) [99]. Bifidobacteria naturally inhabitants the gut 
of animals and humans and their sensitive to oxygen is 
strain related and the less sensitive strain appears to 
possess weak catalase activity that removes H2O2. 
Hydrogen peroxide inactivates Fructos-6-phosphate 
phosphoketolase F6PPK [99], a key enzyme of 
bifidobacteria in carbohydrate metabolism [100,101]. 
Bifidobacteria do not produce CO2, Butyric or propionic 
acid [102]. Their optimum growth temperature is 37 OC 
to 43 OC, and the optimum pH is 6.5 to 7.0 [103]. 
Bifidobacteria also produce thiamine, riboflavin, and 
vitamin B and K [104,105,106,107].  These genera are 
also unique by producing the lactic acid in the form L 
(+)- lactic acid that easier to metabolize by infants in 
compare with the D (-)- lactic acid form which produced 
by L. acidophilus and L. bulgaricus [108].  There are 
three pathways has been suggested for the fermentation 
process of LAB of the carbohydrates to lactate. 
 
The homofermentative pathway, which yields 2 mol of lactate per mol of glucose: 
Glucose 2 lactate
The heterofermentative, which yields 1 mol of each lactate, ethanol, and CO2 per mol of glucose:
Glucose lactate + ethanol + CO2
The bifidum pathway, which yields acetate and lactate in ratio of 3 to 2 respectively:
Glucose 2 lactate + 3 acetate
Homofermentative pathway
Heterofermentative pathway
Bifidum pathway
 
Bifidobacteria metabolized carbohydrate as main carbon 
source is through fructose-6-phosphate shunt by using 
Fructos-6-phosphate phosphoketolase (F6PPK), which is 
distinguishing bifidobacteria from lactobacilli. This 
pathway produces L (+) lactic acid and acetic acid in 
ratio 3:2, some species produce formic acid and ethanol 
as well.  
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Bifidobacteria utilize lactose, galactose and fructose 
beside glucose, and has the ability to metabolize 
oligosaccharides beside the simple sugars such as Inulin, 
FOS etc. This ability is strain related, for example it has 
found that Bifidobacterium Lactis Bb12 possessed the 
enzymes required to utilize somekind of sugar such as 
raffinose family and lactose which are unable to 
metabolism by other strain of bifidobacteria [109]. These 
enzymes which were found in most strains of 
bifidobacteria and not found in the lactic acid bacteria 
[110], Bifidobacterium Lactis Bb12 were found to 
possess the highest activity of such like enzymes which 
found with low activity in other strains, these enzymes 
such as β–glucosidase, α–glucosidase, D-
glucosaminidase and β–galactosidase, which are very 
important in the fermentation process with bifidobacteria 
[111,109]. Bifidobacterium Lactis Bb12 has the ability to 
grow faster in milk because of possessing the highest 
activity of leucine aminopeptidase to help the hydrolysis 
of milk proteins, which stimulate their growth [110,109]. 
 CONCLUSION  
Probiotics are bacteria, often called "good bacteria," 
found mainly in milk-based products. These products 
include yogurt, fermented, unfermented milk and other 
cultured milk products. However, in the case with 
fermented milk products, many times the probiotics are 
added after the fermentation process. While the full 
benefits of probiotics have not been fully explored, there 
are still many professionals who advocate for their use. 
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